Showing results (141-150 of 192) with videos related to
Sort By:
Pageof 20
Liver International : Official Journal of the International Association for the Study of the Liver|July 28, 2015
Liver stiffness plus platelet count can be used to exclude high-risk oesophageal varicesNik S Ding, Tin Nguyen, David M Iser, et al.Internal Medicine Journal|March 5, 2026
Accelerated impact of alcohol-associated hepatitis on healthcare utilisation during the COVID-19 pandemicLeya Nedumannil, Steven Cheema, Simon J Hume, et al.The New England Journal of Medicine|August 16, 2013
Faldaprevir and deleobuvir for HCV genotype 1 infectionStefan Zeuzem, Vincent Soriano, Tarik Asselah, et al.Lancet (London, England)|October 19, 2010
Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trialEdward J Gane, Stuart K Roberts, Catherine A M Stedman, et al.Plos One|December 10, 2015
ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV InfectionTarik Asselah, Stefan Zeuzem, Vicente Soriano, et al.Alimentary Pharmacology & Therapeutics|April 12, 2019
Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levelsAmanda J Nicoll, Stuart K Roberts, Ricky Lim, et al.Biomedicines|August 28, 2025
Genetic Variants, Metabolic Dysfunction-Associated Fatty Liver Disease, and Major Health Outcomes in Older AdultsDaniel Clayton-Chubb, Ammar Majeed, William W Kemp, et al.Journal of Gastroenterology and Hepatology|December 19, 2023
Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of carePaul J Clark, Patricia C Valery, Simone I Strasser, et al.Hepatology (Baltimore, Md.)|January 23, 2014
ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological responseJacinta A Holmes, Stuart K Roberts, Rachel J Ali, et al.The Medical Journal of Australia|July 28, 2025
Assessment of metabolic dysfunction-associated fatty liver disease in primary care: a consensus statement summaryLeon A Adams, William W Kemp, Kate R Muller, et al.Pageof 20